levothyroxine and tirzepatide Thyroid Dysfunction Following Use in a Post-thyroidectomy Patient on Stable Therapy: A Case Study Hashimoto's Thyroiditis: Tirzepatide Case Report

Adverse Reactions in Patients for Weight Reduction and Long-Term Maintenance Pool of Placebo-Controlled Weight Reduction Trials in Adults with Obesity or Overweight, with or without Type 2 Diabetes (Study 1 and Study 2) ZEPBOUND was evaluated for safety in a pool of two randomized, double-blind, placebo-controlled trials that included 2,519 adult patients with obesity or overweight treated with ZEPBOUND for up to 72 weeks and a 4-week off drug follow-up period (Study 1 and Study 2) [see Clinical Studies (14.1)]

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses

Temporary relief that never fully lasts

Ensuring that tool is in peak condition is essential for reaching your goals

N Engl J Med 2021;384(12):111324

In this simulation, tirzepatide was associated with greater weight loss, a lower modeled risk of developing chronic diseases such as T2D and CVD, and lower projected costs than semaglutide